Canada: The Canadian patent (CA 2,675,150) expires December 2028, with no patent term extension granted
O(2) affects mitochondrial functionality ex vivo
(4) Baar MP, Brandt RMC, Putavet DA, Klein JDD, Derks KWJ, Bourgeois BRM, Stryeck S, Rijksen Y, van Willigenburg H, Feijtel DA, van der Pluijm I, Essers J, van Cappellen WA, van IJcken WF, Houtsmuller AB, Pothof J, de Bruin RWF, Madl T, Hoeijmakers JHJ, Campisi J, de Keizer PLJ
Hundreds of people taking GLP-1 brands have reported coming down with anxiety, depression, and suicidal ideation according to the FDA Adverse Event Report System, which leaves room for more questions and hints at more caution
Full weight loss effects take 24 to 48 weeks depending on dose and individual response